New article: The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy. https://t.co/QaRIGnJEQg #CLL #leusm #hematology

Proud of my wife continuing to push the envelope.

RT @UjjaniC: Check out our newest publication! The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy @anthon…

RT @UjjaniC: Check out our newest publication! The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy @anthon…

RT @UjjaniC: Check out our newest publication! The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy @anthon…

Great work led by Dr. @UjjaniC

RT @UjjaniC: Check out our newest publication! The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy @anthon…

RT @UjjaniC: Check out our newest publication! The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy @anthon…

Check out our newest publication! The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy @anthonymatomd @mshadman @LRoekerMD @SeattleCCA @fredhutch https://t.co/yQqUPauy7J

RT @DrRaulCordoba: #OncoAlert The Impact of Age on Survival in #CLL Patients Receiving #Ibrutinib as Initial Therapy #CLLsm #leusm #lymsm #…

#OncoAlert The Impact of Age on Survival in #CLL Patients Receiving #Ibrutinib as Initial Therapy #CLLsm #leusm #lymsm #gerionc #geriheme https://t.co/b6FSOmd8d0

RT @anthonymatomd: New data! The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as I | BLCTT ⁦@UjjaniC⁩ and colleagues ⁦@slo…